Prof.Dr.D.R.NAKIPURIA : GASTRO INTESTINAL & LIVER SPECIALIST

BROAD NEUTRALISING ANTIBODIES FORMED IN LABORATORY WITH CHANGE IN PROTEIN OF HIV VIRUS TO PRODUCE A HIV VACCINE

DIFFICULTY OF PRODUCING EFFECTIVE ANTIBODIES AFTER HIV VACCINATION IS THE DIFFICULT ASPECT OF DEVELOPING VACCINE

TLR7 AGONISTGS-9620 DRUG OF GILEAD COMPANY WILL LIBERATE OUT HIDDEN HIV RESERVOIRS,SO USEFUL TO ERADICATE HIV / AIDS

TWO DRUG DAILY REGIME MAY SOON REPLACE THREE DRUG DAILY REGIME OF HAART/ ARV FOR TREATMENT OF HIV /AIDS PATIENTS

AFRICAN "CENTRE OF DISEASE CONTROL" AS CDC HAS STARTED AS IN AMERICA TO CONTROL HIV,TB,MALARIA AND EBOLA VIRUS IN THIS AREA

HIV as infection causes Inflammation which May Lead to Diabetes in HIV/AIDS People on HIV Medicines-so all patients on arv should test for blood glucose regularly

EARLY TREATMENT OF HIV SOON AFTER ENTRY AND UNIVERSAL TESTING IS GETTING POPULARLITY IN ADVANCED COUNTRIES LIKE USA SO THAT LESS OPPURTUNISTIC INFECTIONS AND BETTER LIFE

HIV/AIDS Vulnerability & treatment failures are more in women than men as more prone for STDs and Hiv infections and lack of adherance in hiv treatment due to social causes

RECENT & COMING NEW RESEARCHES AND ADVANANCES FOR TREATMENT & DIAGNOSIS OF HIV WILL RENDER BETTER QUALITY & QUANTITY OF PATIENT'S LIFE